Prognostic significance of chemotherapy dosage characteristics in children with osteogenic sarcoma

Medical and Pediatric Oncology

Volumn 28, Issue 3, 1997, Pages 179-182

  Leung, S ^a   Marshall, G M ^a   Al Mahr, M ^a   Tobias, V ^a   Lee, D B G ^a   O'Gorman Hughes, D ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

adriamycin; cisplatinum; methotrexate; osteosarcoma; prognosis

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMB SALVAGE; ORAL DRUG ADMINISTRATION; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; HUMANS; METHOTREXATE; MULTIVARIATE ANALYSIS; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0031058728     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199703)28:3<179::AID-MPO4>3.0.CO;2-G     Document Type: Article

References (0)